Your browser doesn't support javascript.
loading
Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway.
Fabris, L; Berton, S; Citron, F; D'Andrea, S; Segatto, I; Nicoloso, M S; Massarut, S; Armenia, J; Zafarana, G; Rossi, S; Ivan, C; Perin, T; Vaidya, J S; Avanzo, M; Roncadin, M; Schiappacassi, M; Bristow, R G; Calin, G; Baldassarre, G; Belletti, B.
Afiliação
  • Fabris L; Division of Experimental Oncology 2, Department of Translational Research, CRO Aviano, National Cancer Institute, Aviano, Italy.
  • Berton S; Division of Experimental Oncology 2, Department of Translational Research, CRO Aviano, National Cancer Institute, Aviano, Italy.
  • Citron F; Princess Margaret Cancer Centre, Departments of Radiation Oncology and Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • D'Andrea S; Division of Experimental Oncology 2, Department of Translational Research, CRO Aviano, National Cancer Institute, Aviano, Italy.
  • Segatto I; Division of Experimental Oncology 2, Department of Translational Research, CRO Aviano, National Cancer Institute, Aviano, Italy.
  • Nicoloso MS; Division of Experimental Oncology 2, Department of Translational Research, CRO Aviano, National Cancer Institute, Aviano, Italy.
  • Massarut S; Division of Experimental Oncology 2, Department of Translational Research, CRO Aviano, National Cancer Institute, Aviano, Italy.
  • Armenia J; MD Anderson Cancer Center, Department of Experimental Therapeutics, Houston, TX, USA.
  • Zafarana G; Breast Surgery Unit, Department of Oncology and Surgery, CRO Aviano, National Cancer Institute, Aviano, Italy.
  • Rossi S; Division of Experimental Oncology 2, Department of Translational Research, CRO Aviano, National Cancer Institute, Aviano, Italy.
  • Ivan C; Princess Margaret Cancer Centre, Departments of Radiation Oncology and Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Perin T; MD Anderson Cancer Center, Department of Experimental Therapeutics, Houston, TX, USA.
  • Vaidya JS; MD Anderson Cancer Center, Department of Experimental Therapeutics, Houston, TX, USA.
  • Avanzo M; Pathology Unit, Department of Translational Research, CRO Aviano, National Cancer Institute, Aviano, Italy.
  • Roncadin M; Division of Surgery and Interventional Science, University College London, London, UK.
  • Schiappacassi M; Medical Physics Unit, Department of Oncology and Radiotherapy, CRO Aviano, National Cancer Institute, Aviano, Italy.
  • Bristow RG; Radiotherapy Unit, Department of Oncology and Radiotherapy, CRO Aviano,National Cancer Institute, Aviano, Italy.
  • Calin G; Division of Experimental Oncology 2, Department of Translational Research, CRO Aviano, National Cancer Institute, Aviano, Italy.
  • Baldassarre G; Princess Margaret Cancer Centre, Departments of Radiation Oncology and Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Belletti B; MD Anderson Cancer Center, Department of Experimental Therapeutics, Houston, TX, USA.
Oncogene ; 35(37): 4914-26, 2016 09 15.
Article em En | MEDLINE | ID: mdl-26876200

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / MicroRNAs / Fator de Crescimento Epidérmico / Receptores ErbB / Recidiva Local de Neoplasia Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / MicroRNAs / Fator de Crescimento Epidérmico / Receptores ErbB / Recidiva Local de Neoplasia Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Itália
...